[This corrects the article DOI: 10.1371/journal.pmed.1002204.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400239PMC
http://dx.doi.org/10.1371/journal.pmed.1002302DOI Listing

Publication Analysis

Top Keywords

correction subclonal
4
subclonal architecture
4
architecture metastatic
4
metastatic breast
4
breast cancer
4
cancer prospective
4
prospective community-based
4
community-based rapid
4
rapid autopsy
4
autopsy program
4

Similar Publications

To investigate the clinicopathological and molecular genetic features of POLE mutant endometrioid carcinoma. Genetic test data of 230 cases of endometrial carcinoma that underwent surgical resection and molecular typing by next generation sequencing in the First Medical Center of Chinese PLA General Hospital from January 2021 to June 2023 were retrospectively analyzed. Seventeen cases of endometrioid carcinoma with POLE mutation were selected.

View Article and Find Full Text PDF

Background: Interferon-beta (IFN-β) is a cytokine with a wide range of biological and pharmaceutical applications, including multiple sclerosis (MS), cancer, some autoimmune disorders, and viral infectious diseases. Thus, many studies have been performed to develop novel strategies for the high-yield production of functional IFN-β in a cost-effective approach. Here, we aimed to improve the intracellular expression of IFN-β-1a in .

View Article and Find Full Text PDF

STK11 (LKB1) immunohistochemistry is a sensitive and specific marker for STK11 adnexal tumours.

Histopathology

November 2024

Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Article Synopsis
  • - STK11 adnexal tumours are rare malignant neoplasms associated with Peutz-Jeghers syndrome, primarily arising from para-adnexal soft tissues and potentially affecting the fallopian tube and ovary; diagnosis currently involves identifying STK11 mutations.
  • - Researchers conducted immunohistochemistry (IHC) on 122 tumours, including 17 STK11 adnexal tumours and 105 lookalikes; results showed that STK11 adnexal tumours had complete loss of STK11 protein expression, while other tumour types generally retained it.
  • - The study concludes that STK11 serves as a sensitive and specific marker for distinguishing STK11 adnexal tumours
View Article and Find Full Text PDF

Unlabelled: Genomic analysis of the T-cell receptor (TCR) reveals the strength, breadth, and clonal dynamics of the adaptive immune response to pathogens or cancer. The diversity of the TCR repertoire, however, means that sequencing is technically challenging, particularly for samples with low-quality, degraded nucleic acids. Here, we developed and validated FUME-TCRseq, a robust and sensitive RNA-based TCR sequencing methodology that is suitable for formalin-fixed paraffin-embedded samples and low amounts of input material.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!